BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 8634448)

  • 1. Elevation of cerebrospinal fluid soluble CD27 levels in patients with meningeal localization of lymphoid malignancies.
    Kersten MJ; Evers LM; Dellemijn PL; van den Berg H; Portegies P; Hintzen RQ; van Lier RA; von dem Borne AE; van Oers RH
    Blood; 1996 Mar; 87(5):1985-9. PubMed ID: 8634448
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Levels of serum and cerebrospinal fluid soluble CD27 in the diagnosis of leptomeningeal involvement of hematolymphoid malignancies.
    Kara IO; Sahin B; Gunesacar R
    Adv Ther; 2007; 24(4):741-7. PubMed ID: 17901023
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnostic utility of CSF soluble CD27 for primary central nervous system lymphoma in immunocompetent patients.
    Murase S; Saio M; Andoh H; Takenaka K; Shinoda J; Nishimura Y; Sakai N; Takami T
    Neurol Res; 2000 Jul; 22(5):434-42. PubMed ID: 10935213
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cerebrospinal fluid soluble CD27 levels in children with non-Hodgkin lymphomas.
    Yalçin B; Canpinar H; Kutluk MT; Varan A; Akyüz C; Büyükpamukçu M
    Pediatr Hematol Oncol; 2004 Dec; 21(8):717-23. PubMed ID: 15739627
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Significance of elevated levels of soluble factors in the cerebrospinal fluid in patients with adult T-cell leukemia.
    Uozumi K; Ishitsuka K; Ohno N; Nakahara K; Utsunomiya A; Hanada S; Arima T
    Leuk Lymphoma; 1995 Nov; 19(5-6):437-45. PubMed ID: 8590844
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased levels of soluble CD27 in the cerebrospinal fluid are not diagnostic for leptomeningeal involvement by lymphoid malignancies.
    van den Bent MJ; Lamers CH; van 't Veer MB; Sillevis Smitt PA; Bolhuis RL; Gratama JW
    Ann Hematol; 2002 Apr; 81(4):187-91. PubMed ID: 11976819
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased levels of CSF soluble CD27 in patients with primary central nervous system lymphoma.
    Murase S; Saio M; Takenaka K; Shinoda J; Nishimura Y; Sakai N; Takami T
    Cancer Lett; 1998 Oct; 132(1-2):181-6. PubMed ID: 10397472
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cerebrospinal fluid neopterin levels in children with central nervous system leukemia.
    Millot F; Dhondt JL; Mazingue F; Mechinaud F; Auget JL; Bauters F; Harousseau JL
    Leuk Lymphoma; 1993 Mar; 9(4-5):351-6. PubMed ID: 8348070
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Soluble CD27 Levels in Cerebrospinal Fluid as a Prognostic Biomarker in Clinically Isolated Syndrome.
    van der Vuurst de Vries RM; Mescheriakova JY; Runia TF; Jafari N; Siepman TA; Hintzen RQ
    JAMA Neurol; 2017 Mar; 74(3):286-292. PubMed ID: 28055081
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aberrant expression of CD27 and soluble CD27 (sCD27) in HIV infection and in AIDS-associated lymphoma.
    Widney D; Gundapp G; Said JW; van der Meijden M; Bonavida B; Demidem A; Trevisan C; Taylor J; Detels R; Martínez-Maza O
    Clin Immunol; 1999 Nov; 93(2):114-23. PubMed ID: 10527687
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinical significance of soluble interleukin-2 receptor levels in the cerebrospinal fluid in patients with adult T-cell leukemia complicated with meningeal infiltration].
    Tanaka K; Shiraishi K; Sakamoto A; Okubo Y; Fukuda Y; Fukahori S; Jojima H; Osabe S; Honda J; Natori H; Oizumi K
    Gan To Kagaku Ryoho; 1996 Jun; 23(7):863-9. PubMed ID: 8678534
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression and release of CD27 in human B-cell malignancies.
    van Oers MH; Pals ST; Evers LM; van der Schoot CE; Koopman G; Bonfrer JM; Hintzen RQ; von dem Borne AE; van Lier RA
    Blood; 1993 Dec; 82(11):3430-6. PubMed ID: 8241510
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Humoral CSF parameters in the differential diagnosis of hematologic CNS neoplasia.
    Weller M; Stevens A; Sommer N; Schabet M; Wiethölter H
    Acta Neurol Scand; 1992 Aug; 86(2):129-33. PubMed ID: 1414221
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum soluble CD27, but not thymidine kinase, is an independent prognostic factor for outcome in indolent non-Hodgkin's lymphoma.
    Kok M; Bonfrer JM; Korse CM; de Jong D; Kersten MJ
    Tumour Biol; 2003; 24(1):53-60. PubMed ID: 12743427
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characteristics of Central Nervous System (CNS) Involvement in Children With Non-Hodgkin's Lymphoma (NHL) and the Diagnostic Value of CSF Flow Cytometry in CNS Positive Disease.
    Huang S; Jin L; Yang J; Duan Y; Zhang M; Zhou C; Zhang YH
    Technol Cancer Res Treat; 2021; 20():15330338211016372. PubMed ID: 34060372
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cerebrospinal fluid concentrations of soluble CD27 in HTLV-I associated myelopathy and multiple sclerosis.
    Hintzen RQ; Paty D; Oger J
    J Neurol Neurosurg Psychiatry; 1999 Jun; 66(6):791-3. PubMed ID: 10329758
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cerebrospinal fluid beta-2-microglobulin in adult patients with acute leukemia or lymphoma: a useful marker in early diagnosis and monitoring of CNS-involvement.
    Hansen PB; Kjeldsen L; Dalhoff K; Olesen B
    Acta Neurol Scand; 1992 Mar; 85(3):224-7. PubMed ID: 1575009
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Soluble TACI and soluble BCMA as biomarkers in primary central nervous system lymphoma.
    Thaler FS; Laurent SA; Huber M; Mulazzani M; Dreyling M; Ködel U; Kümpfel T; Straube A; Meinl E; von Baumgarten L
    Neuro Oncol; 2017 Nov; 19(12):1618-1627. PubMed ID: 28521029
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Measurement of sCD27 in the cerebrospinal fluid identifies patients with neuroinflammatory disease.
    Feresiadou A; Nilsson K; Ingelsson M; Press R; Kmezic I; Nygren I; Svenningsson A; Niemelä V; Gordh T; Cunningham J; Kultima K; Larsson A; Burman J
    J Neuroimmunol; 2019 Jul; 332():31-36. PubMed ID: 30928869
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection of central nervous system involvement in patients with leukemia or non-Hodgkin's lymphoma by immunological marker analysis of cerebrospinal fluid cells.
    Hooijkaas H; Adriaansen HJ; van Dongen JJ
    Cancer Treat Res; 1988; 38():149-71. PubMed ID: 2908594
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.